✦ LIBER ✦

Demonstration of specific antibodies against infliximab induced during treatment of a patient with ankylosing spondylitis

✍ Scribed by Canan Aybay; Sumru Ozel; Cemalettin Aybay

Publisher: Springer
Year: 2005
Tongue: English
Weight: 308 KB
Volume: 26
Category: Article
ISSN: 0172-8172
DOI: 10.1007/s00296-005-0085-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of leprosy in a patient with

Development of leprosy in a patient with ankylosing spondylitis during the infliximab treatment: reactivation of a latent infection?

✍ Roberta Vilela Lopes; Claudia Barros Ohashi; Luiza Helena Cavaleiro; Rosana de B 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 103 KB

Reintroduction of etanercept during trea

Reintroduction of etanercept during treatment of cutaneousMycobacterium marinuminfection in a patient with ankylosing spondylitis

✍ Dare, Jason A. ;Jahan, Shormi ;Hiatt, Kim ;Torralba, Karina D. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

Down-regulation of the nonspecific and a

Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab

✍ Jianxiang Zou; Martin Rudwaleit; Jan Brandt; Andreas Thiel; Jürgen Braun; Joachi 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 1 views

Infliximab, a TNF-alpha antagonist treat

Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level

✍ I. Ertenli; S. Ozer; S. Kiraz; S. B. Apras; A. Akdogan; O. Karadag; M. Calguneri 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 235 KB

Major reduction in spinal inflammation i

Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: Results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study

✍ Jürgen Braun; Robert Landewé; Kay-Geert A. Hermann; John Han; Songkai Yan; Paul 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB 👁 2 views

## Abstract ## Objective To determine whether the effects of anti–tumor necrosis factor α (TNFα) in reducing the signs and symptoms of ankylosing spondylitis (AS) coincide with a reduction in spinal inflammation as detected by magnetic resonance imaging (MRI). ## Methods Pre‐ and postgadolinium

Efficacy of celecoxib, a cyclooxygenase

Efficacy of celecoxib, a cyclooxygenase 2–specific inhibitor, in the treatment of ankylosing spondylitis: A six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug

✍ Maxime Dougados; Jehan-Michel Béhier; Irène Jolchine; Andrei Calin; Désirée van 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views